Single Dose Of AS01E-Adjuvanted RSV Prefusion F Protein-Based Vaccine Elicits RSV-A And RSV-B-Specific Immune Responses Among Older Adults, Study Finds

Infectious Disease Advisor (1/8, Nye) reports, “A single dose of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine elicits RSV-A and RSV-B-specific immune responses among older adults.” The findings were published in The Journal of Infectious Diseases.